ロード中...
The Cost Effectiveness of Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the USA
BACKGROUND: Lisdexamfetamine dimesylate (LDX) demonstrated efficacy in terms of reduced binge eating days per week in adults with binge eating disorder (BED) in two randomized clinical trials (RCTs). OBJECTIVE: The objective of this study was to evaluate the cost effectiveness of LDX versus no pharm...
保存先:
| 出版年: | Clin Drug Investig |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4801997/ https://ncbi.nlm.nih.gov/pubmed/26914658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-016-0381-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|